High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902-Reference-Cited by-同舟云学术

High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902

Published:2011-03 Issue:3 Volume:35 Page:329-333
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Stone Richard M.,Moser Barry,Sanford Ben,Schulman Philip,Kolitz Jonathan E.,Allen Steven,Stock Wendy,Galinsky Ilene,Vij Ravi,Marcucci Guido,Hurd David,Larson Richard A.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference28 articles.

1. Optimizing therapy for acute myeloid leukemia;Kohrt;JNCCN,2008

2. Acute myelogenous leukemia in older adults;Klepin;Oncologist,2009

3. Novel strategies for relapsed and refractory acute myeloid leukemia;Mato;Curr Opin Hematol,2008

4. Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML);Appelbaum;Bailliere's Best Pract Clin Haematol,2008

5. Acute myeloid leukemia and the position of autologous stem cell transplantation;Breems;Semin Hematol,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience;HemaSphere;2024-07

2. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?;Journal of Clinical Medicine;2024-01-18

3. Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia;Clinical oncohematology;2021

4. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults;Expert Opinion on Biological Therapy;2020-10-05

5. LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY;Mediterranean Journal of Hematology and Infectious Diseases;2020-04-27